Influence of downstream processing parameters on post-translational modifications of the AAV capsid
Radukic M, Luttermann T, Pries A, Müller B, Müller K (2022)
In: ESGCT 29th Annual Congress. In collaboration with BSGCT Edinburgh, UK October 11–14, 2022, Abstracts. Human Gene Therapy, 33(23-24). Mary Ann Liebert: A98.
Kurzbeitrag Konferenz / Poster
| Veröffentlicht | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Erscheinungsjahr
2022
Titel des Konferenzbandes
ESGCT 29th Annual Congress. In collaboration with BSGCT Edinburgh, UK October 11–14, 2022, Abstracts
Serien- oder Zeitschriftentitel
Human Gene Therapy
Band
33
Ausgabe
23-24
Seite(n)
A98
Konferenz
29th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy (ESCGT)
Konferenzort
Edinburgh, UK
Konferenzdatum
2022-10-11 – 2022-10-14
ISSN
1043-0342
eISSN
1557-7422
Page URI
https://pub.uni-bielefeld.de/record/2968508
Zitieren
Radukic M, Luttermann T, Pries A, Müller B, Müller K. Influence of downstream processing parameters on post-translational modifications of the AAV capsid. In: ESGCT 29th Annual Congress. In collaboration with BSGCT Edinburgh, UK October 11–14, 2022, Abstracts. Human Gene Therapy. Vol 33. Mary Ann Liebert; 2022: A98.
Radukic, M., Luttermann, T., Pries, A., Müller, B., & Müller, K. (2022). Influence of downstream processing parameters on post-translational modifications of the AAV capsid. ESGCT 29th Annual Congress. In collaboration with BSGCT Edinburgh, UK October 11–14, 2022, Abstracts, Human Gene Therapy, 33, A98. Mary Ann Liebert. https://doi.org/10.1089/hum.2022.29225.abstracts
Radukic, Marco, Luttermann, T., Pries, A., Müller, B., and Müller, Kristian. 2022. “Influence of downstream processing parameters on post-translational modifications of the AAV capsid”. In ESGCT 29th Annual Congress. In collaboration with BSGCT Edinburgh, UK October 11–14, 2022, Abstracts, 33:A98. Human Gene Therapy. Mary Ann Liebert.
Radukic, M., Luttermann, T., Pries, A., Müller, B., and Müller, K. (2022). “Influence of downstream processing parameters on post-translational modifications of the AAV capsid” in ESGCT 29th Annual Congress. In collaboration with BSGCT Edinburgh, UK October 11–14, 2022, Abstracts Human Gene Therapy, vol. 33, (Mary Ann Liebert), A98.
Radukic, M., et al., 2022. Influence of downstream processing parameters on post-translational modifications of the AAV capsid. In ESGCT 29th Annual Congress. In collaboration with BSGCT Edinburgh, UK October 11–14, 2022, Abstracts. Human Gene Therapy. no.33 Mary Ann Liebert, pp. A98.
M. Radukic, et al., “Influence of downstream processing parameters on post-translational modifications of the AAV capsid”, ESGCT 29th Annual Congress. In collaboration with BSGCT Edinburgh, UK October 11–14, 2022, Abstracts, Human Gene Therapy, vol. 33, Mary Ann Liebert, 2022, pp.A98.
Radukic, M., Luttermann, T., Pries, A., Müller, B., Müller, K.: Influence of downstream processing parameters on post-translational modifications of the AAV capsid. ESGCT 29th Annual Congress. In collaboration with BSGCT Edinburgh, UK October 11–14, 2022, Abstracts. Human Gene Therapy. 33, p. A98. Mary Ann Liebert (2022).
Radukic, Marco, Luttermann, T., Pries, A., Müller, B., and Müller, Kristian. “Influence of downstream processing parameters on post-translational modifications of the AAV capsid”. ESGCT 29th Annual Congress. In collaboration with BSGCT Edinburgh, UK October 11–14, 2022, Abstracts. Mary Ann Liebert, 2022.Vol. 33. Human Gene Therapy. A98.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Suchen in
Google Scholar